MLC1 (Middle Region) Peptid
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
-
- Target Alle MLC1 Produkte
- MLC1
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-MLC1 antibody (Catalog #: ARP35249_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MLC1
- Hintergrund
-
MLC1 may be a transporter. It may act as a non-selective neuronal cation channel.The function of this gene product is unknown, however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified.
Alias Symbols: KIAA0027, LVM, MLC, VL
Protein Interaction Partner: DAPK2,TPT1,MYLK
Protein Size: 377 - Molekulargewicht
- 41 kDa
- Gen-ID
- 23209
- NCBI Accession
- NM_015166, NP_055981
- UniProt
- Q15049
-
Sie sind hier:
